Over The Counter (OTC) Drugs Market Report

Over The Counter (OTC) Drugs Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 19, 2020
  • PAGES：177
  • REPORT CODE：GMM441031
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Over The Counter (OTC) Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.0% during the forecast period.

    This report presents the market size and development trends by detailing the Over The Counter (OTC) Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Over The Counter (OTC) Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Over The Counter (OTC) Drugs industry and will help you to build a panoramic view of the industrial development.

    Over The Counter (OTC) Drugs Market, By Type:

    • Analgesics

    • Dermatology Products

    • Gastrointestinal Products

    • Vitamins, Mineral, and Supplements (VMS)

    • Weight Loss/Dietary Products

    • Ophthalmic Products

    • Sleeping Aids

    • Others

    Over The Counter (OTC) Drugs Market, By Application:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacy

    • Others

    Some of the leading players are as follows:

    • Sanofi SA

    • Johnson & Johnson

    • Pfizer,Inc

    • PGT healthcare

    • Takeda.

    • Sanofi S.A

    • Novartis International AG

    • Bayer AG

    • Boehringer Ingelheim

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Over The Counter (OTC) Drugs Market: Technology Type Analysis

    • 4.1 Over The Counter (OTC) Drugs Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Over The Counter (OTC) Drugs Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Analgesics

      • 4.3.2 Dermatology Products

      • 4.3.3 Gastrointestinal Products

      • 4.3.4 Vitamins, Mineral, and Supplements (VMS)

      • 4.3.5 Weight Loss/Dietary Products

      • 4.3.6 Ophthalmic Products

      • 4.3.7 Sleeping Aids

      • 4.3.8 Others

    5 Over The Counter (OTC) Drugs Market: Product Analysis

    • 5.1 Over The Counter (OTC) Drugs Product Market Share Analysis, 2018 & 2026

    • 5.2 Over The Counter (OTC) Drugs Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Over The Counter (OTC) Drugs Market: Application Analysis

    • 6.1 Over The Counter (OTC) Drugs Application Market Share Analysis, 2018 & 2026

    • 6.2 Over The Counter (OTC) Drugs Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital Pharmacies

      • 6.3.2 Retail Pharmacies

      • 6.3.3 Online Pharmacy

      • 6.3.4 Others

    7 Over The Counter (OTC) Drugs Market: Regional Analysis

    • 7.1 Over The Counter (OTC) Drugs Regional Market Share Analysis, 2018 & 2026

    • 7.2 Over The Counter (OTC) Drugs Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Sanofi SA

      • 9.1.1 Sanofi SA Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Johnson & Johnson

      • 9.2.1 Johnson & Johnson Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Pfizer,Inc

      • 9.3.1 Pfizer,Inc Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 PGT healthcare

      • 9.4.1 PGT healthcare Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Takeda.

      • 9.5.1 Takeda. Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Sanofi S.A

      • 9.6.1 Sanofi S.A Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Novartis International AG

      • 9.7.1 Novartis International AG Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Bayer AG

      • 9.8.1 Bayer AG Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Boehringer Ingelheim

      • 9.9.1 Boehringer Ingelheim Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

     

    The List of Tables and Figures (Totals 74 Figures and 139 Tables)

    • Figure Analgesics Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Dermatology Products Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Gastrointestinal Products Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Vitamins, Mineral, and Supplements (VMS) Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Weight Loss/Dietary Products Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Ophthalmic Products Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Sleeping Aids Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Others Over The Counter (OTC) Drugs market, 2015 - 2026 (USD Million)

    • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

    • Figure Retail Pharmacies market, 2015 - 2026 (USD Million)

    • Figure Online Pharmacy market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Over The Counter (OTC) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table North America Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table North America Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table North America Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Canada Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Canada Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Europe Over The Counter (OTC) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Europe Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Europe Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Europe Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Germany Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Germany Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table France Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table France Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Italy Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Italy Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Spain Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Spain Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Over The Counter (OTC) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table China Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table China Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Japan Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Japan Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table India Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table India Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Over The Counter (OTC) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table MEA Over The Counter (OTC) Drugs market, by country, 2015 - 2026 (USD Million)

    • Table MEA Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table MEA Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table MEA Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Over The Counter (OTC) Drugs market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Over The Counter (OTC) Drugs market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Over The Counter (OTC) Drugs market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Sanofi SA Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer,Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table PGT healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Takeda. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanofi S.A Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis International AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US